Skip to content
Home/Companies/Healthcare IT/Instem
Instem

Instem

Healthcare IT·US·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Instem?

Instem is currently owned by ARCHIMED through MED Platform II (2022 vintage), since 2023.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED Platform II · 2022 · Buyout

Key facts

HQUnited States
SectorHealthcare IT
Websitewww.instem.com

More from MED Platform II

Other portfolio companies in the same fund.

Esperion Therapeutics
Active
· 2026
ARK Diagnostics
Active
MedTechUS· 2025
Symbio
Symbio
Active
PharmaUS· 2023
WiQo
WiQo
Active
HealthTechItaly· 2023
Corealis
Corealis
Active
PharmaCanada· 2022
Natus
Natus
Active
MedTechUS· 2022

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
agilon health
agilon health
Active
CD&RUS
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Track Instem

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Instem.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue